Former Bachelorette star Katie Thurston is sharing a major update on her cancer journey after having to put her treatments on ...

Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...

Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ ...

Women with advanced breast cancer could soon have access to a new targeted treatment on the NHS, following a decision by the National Institute for Health and Care Excellence (NICE). The tablet ...

A Nigerian researcher, Dr Jerry Adeyemo, has identified alternative therapies that could help in the treatment of prostate ...

The Coordinator of the National Cancer Control Programme, Ministry of Health and Social Welfare, Dr Uche Nwokwu, has said ...

The treatment of prostate cancer in Uganda follows similar principles to those used worldwide, including surgery, radiation therapy, chemotherapy, and hormone therapy. However, the availability of ...

The conversation around breast cancer and hormone therapy can feel confusing. What we know: using estrogen and progestogen together (for those who have a uterus) is linked to a small increased ...

The biotechnology company said its Bria-IMT plus check point inhibitors showed a 17.3-month survival rate for patients with hormone receptor-positive breast cancer, exceeding the 14.4 months of ...

Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.